Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

3901 - 3910 of 44782 results found

Host Receptor Targeting to Treat Covid-19

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
Not long after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of coronavirus disease 2019 (Covid-19), in vitro experiments revealed that SARS-CoV-2 infection of human cells depended on the binding of the

A Randomized Trial of Nafamostat for Covid-19

Date
Tuesday, February 06, 2024 - 4:00 AM
Description
A Randomized Trial of Nafamostat for Covid-19Nafamostat mesylate is a potent in vitro antiviral that inhibits the host transmembrane protease serine 2 enzyme used by SARS-CoV-2 for cell entry. Morpeth et al report the results of an open-label